The Companies

Kode Biotech Limited & Kode Biotech Materials Limited
Kode Biotech Limited is a private company established in 1996 to commercialise and license Kode™ Technology. In 2009, a second separate company was formed, Kode Biotech Materials Ltd. Kode Biotech Ltd is the licensor of existing, and developer of new Kode™ Technology. Kode Biotech Materials Ltd is an authorized supplier of Kode™ FSL constructs and operates under quality standards. Both companies, although separate legal entities, are represented by this website.

Kode™ Technology has already been licensed to several large companies, and an example of a product incorporating Kode™ Technology that is already in the market is Securacell™

Kode Biotech Ltd and Kode Biotech Materials Ltd, are independent companies, both situated on the Auckland University of Technology (AUT) Wellesley Street campus and have forged a strong symbiotic relationship with AUT's Centre for Kode Technology Innovation (KTI).

Management

Stephen Henry

CHIEF EXECUTIVE OFFICER (Kode Biotech Ltd)
MANAGING DIRECTOR (Kode Biotech Materials Ltd)
Kode Biotech Limited was founded in 1996 by Stephen Henry. Stephen is additionally a Professor at AUT University (Chief Executive - Biotechnology, Scott Laboratory and the Centre for Kode Technology Innovation, Faculty of Design and Creative Technologies). Stephen has a strong research and management background, holding PhD's in Biochemistry (Auckland) and Medicine (Göteborg), plus other tertiary qualifications in science/laboratory medicine, education and business. He has published over 150 scientific articles, and is an inventor on numerous patent applications in 20 Kode™ Technology patent families.
Stephen's main hobby is coastal sailing on his cruising yacht, Iemanja.

Nicolai Bovin

CHIEF SCIENTIFIC OFFICER (Kode Biotech Ltd)

Chris Trent

BUSINESS DEVELOPMENT ASSOCIATE (Kode Biotech Ltd)
COMMERCIALISATION MANAGER (Kode Biotech Materials Ltd)
Chris joined Kode Biotech Limited in September 2015 as the business development associate for Kode Biotech and the commercialisation manager for Kode Biotech Materials.

Bill Chien

MARKET ANALYST (Kode Biotech Ltd)
Bill joined Kode Biotech in April 2016 as the market analyst and part of the business development team.

Board of Directors

David Ross

(CHAIRMAN)
David is a chartered accountant with a broad business background. David is a director of a significant number of private companies in New Zealand and Australia and has been actively involved with start-up businesses for the past 20 years. He has a specific interest in high technology projects. David operates a consultancy practice focussed mainly on the corporate sector.

Stephen Henry

(CHIEF EXECUTIVE OFFICER)
Stephen is the founder of Kode Biotech Limited amd is also a Professor at Auckland University of Technology (Chief Executive - Biotechnology, Scott Laboratory, Faculty of Design and Creative Technologies). Stephen has a strong research and management background holding PhD's in Biochemistry (Auckland) and Medicine (Göteborg), plus other tertiary qualifications in science/laboratory medicine, education and business. He has published over 150 scientific articles, and is an inventor on more than 20 Kode™ Technology patent applications.

Nick Olson

(NON-EXECUTIVE DIRECTOR)

Intellectual Property

Stephen Parker

(IN-HOUSE PATENT ATTORNEY)
Stephen has an Honours degree in microbiology and a doctoral degree in Biochemistry from the University of Cambridge. He has teaching and research experience in molecular and cell biology, microbiology, biochemistry, and analytical and organic chemistry. He has held postdoctoral research appointments with the United States Department of Agriculture and the Horticulture and Food Research Institute of New Zealand.
Stephen uses his information retrieval expertise to evaluate both the intellectual property and regulatory environments for a proposed product. Stephen then assists clients to develop product commercialisation strategies that minimise the time to market and risk of unnecessary expenditure.
For a proposed chemical or biological product Stephen prepares and files applications for intellectual property protection (including the drafting of patent specifications) as well as applications for marketing approval under legislation such as the Agricultural Compounds and Veterinary Medicines Act 1997 and the Hazardous Substances and New Organisms Act 1996.